SB
SV Biotech Crossover Opportunities Fund LP disclosed a 7% stake in TRXB
SV Biotech Crossover Opportunities Fund LP reported owning 7% of TRex Bio, Inc. (TRXB) (1,920,667 shares) in a Schedule 13D filed Oct 16, 2026.
A 13D means the holder may push for changes at the company.